BIOLASE, Inc. (BIOL)
OTCMKTS: BIOL · Delayed Price · USD
0.0687
-0.0063 (-8.40%)
Jul 19, 2024, 4:00 PM EDT - Market closed
BIOLASE Employees
BIOLASE had 157 employees as of December 31, 2023. The number of employees decreased by 35 or -18.23% compared to the previous year.
Employees
157
Change (1Y)
-35
Growth (1Y)
-18.23%
Revenue / Employee
$311,006
Profits / Employee
-$135,465
Market Cap
2.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
BIOL News
- 4 weeks ago - BIOLASE Announces Delisting from Nasdaq - Accesswire
- 2 months ago - Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability - Accesswire
- 2 months ago - BIOLASE to Report First Quarter 2024 Results on May 13, 2024 - Accesswire
- 4 months ago - Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 - Accesswire
- 4 months ago - BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 - Accesswire
- 5 months ago - Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry - Accesswire
- 5 months ago - Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' - Accesswire
- 5 months ago - BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering - Accesswire